bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Shares Shorted: Short Interest Down 85.9% in September

by · The Markets Daily

bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 445 shares, a decrease of 85.9% from the August 31st total of 3,162 shares. Based on an average daily trading volume, of 30,259 shares, the short-interest ratio is currently 0.0 days.

bioAffinity Technologies Stock Down 12.5%

Shares of BIAFW stock traded down $0.04 during trading on Friday, hitting $0.28. 1,118 shares of the stock traded hands, compared to its average volume of 5,427. bioAffinity Technologies has a 52-week low of $0.05 and a 52-week high of $0.98. The firm’s fifty day moving average price is $0.20 and its 200-day moving average price is $0.23.

About bioAffinity Technologies

(Get Free Report)

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.

Featured Stories